Freestone Grove Partners »

Maze Therapeatics shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.9M 119k 41.43

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Boston Scientific Corporation (BSX)
Ametek (AME)
Encana Corporation (OVV)
First Horizon National Corporation (FHN)
Charles Schwab Corporation (SCHW)
Anthem (ELV)
MasTec (MTZ)
Fortune Brands (FBIN)
Xcel Energy (XEL)
Lennar Corp Cl A (LEN)
Martin Marietta Materials (MLM)
Danaher Corporation (DHR)

View all positions for Freestone Grove Partners

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics